Does Wegovy Keep You Awake at Night?

You started Wegovy last week and now you're lying awake at 2am

It's a common enough story. You began treatment feeling hopeful, got through the first injection without drama, and then found yourself wide-eyed in the early hours wondering whether the medicine is to blame. The short answer is: probably not directly, but indirectly it's very possible.

Wegovy works through GLP-1 receptors that regulate appetite, fullness and gastric emptying. There's no stimulant in it, no caffeine-like pathway, and nothing that tells your nervous system to stay alert. What it does do, especially in the first few weeks, is slow the movement of food through your stomach. For some people that creates nausea, reflux or a feeling of fullness that lingers well into the evening. Lying flat with an uncomfortable stomach is not a recipe for good sleep. The NHS semaglutide medicines page lists nausea, vomiting and indigestion among the most common side effects, particularly at the start of treatment or after a dose increase, and these tend to settle within days to a couple of weeks as your body adjusts.

A quick habit worth building: check what time you ate your last main meal. GLP-1 medicines slow gastric emptying considerably, so a large meal at 7pm can sit with you until midnight in a way it never did before. Shifting dinner earlier, keeping portions moderate and avoiding very fatty foods in the evening can make a noticeable difference to how settled you feel by bedtime.

For context on how the wider range of Wegovy's effects tend to evolve over time, the Wegovy overview at nume covers the full treatment picture.

When disrupted sleep might actually be a sign something else is going on

Not every night-time symptom traces back to nausea. A handful of other Wegovy-adjacent experiences are worth considering.

Anxiety and low mood can occur for some people on GLP-1 medicines, and both are well-established disruptors of sleep. If you've noticed a shift in how you're feeling emotionally since starting treatment, that's worth raising with your prescriber rather than waiting to see if it passes. There's a separate thread of evidence around whether semaglutide might actually benefit mood in some people (researchers are actively exploring this) but it cuts both ways, and any meaningful emotional change deserves clinical attention. The relationship between Wegovy and mood is something our clinical team are asked about regularly.

Temperature changes are another underappreciated factor. Some people on Wegovy notice they feel warmer or colder than usual, both can affect sleep quality. If you're kicking the duvet off or piling blankets on without an obvious reason, it may be treatment-related. The pages on feeling hot on Wegovy and feeling cold on Wegovy go into the detail on each.

Vivid dreams are occasionally mentioned by people on semaglutide, though they don't appear in the formal side-effect lists as a recognised common effect. If they're bothering you, log them and mention them at your next review. A prescriber can't act on something they don't know about.

The other side: could Wegovy actually improve your sleep?

There's real reason to think it might, for some people. Obstructive sleep apnoea is one of the weight-related conditions for which Wegovy is licensed as a treatment indication, and weight reduction itself is associated with meaningfully improved sleep quality in people where excess weight was compressing the airway or fragmenting sleep cycles.

The NHS England guidance on weight-management injections lists sleep apnoea as one of the qualifying conditions for treatment, which reflects the strength of the biological connection. If you snored heavily before starting and find that's lessened, or if you feel more rested in the mornings than you did six months ago, that's not coincidence, it's consistent with what the trials showed. There's also an emerging strand of research on whether GLP-1 medicines may have direct effects on sleep architecture, though that evidence is not yet settled enough to make firm claims about.

For people interested in whether poor sleep itself affects weight loss or appetite, there's a dedicated page on how Wegovy relates to sleep more broadly. And if you're thinking about how your nutrition alongside treatment might be affecting how you feel in the evenings, the Wegovy nutrition guide is a practical starting point.

When to tell someone rather than wait it out

Most sleep disruption in the early weeks of Wegovy settles on its own, in step with the GI side effects that often cause it. But there are signals that warrant a conversation sooner rather than later.

Tell your prescriber if: sleep problems began precisely after a dose increase and haven't improved after two weeks; you're experiencing chest pain, palpitations or shortness of breath at night; you have severe or persistent stomach pain, particularly if it radiates to your back (acute pancreatitis, though uncommon, requires urgent medical attention, the MHRA highlighted this risk in a Drug Safety Update for GLP-1 medicines); or if you're feeling significantly more anxious or low than before you started. These aren't reasons to stop treatment without advice, but they are reasons not to sit on it.

You can report any suspected side effects through the MHRA's Yellow Card scheme, which helps build the ongoing safety picture for medicines like Wegovy. And if you'd like a clinical eye on what you're experiencing, speaking to our prescribers is the straightforward next step. Start your free consultation and a GPhC-registered prescriber, not an algorithm, will read your answers the same day.